IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Invivo Therapeutics Hldgs Co

CUSIP: 46186M605 | 36 institutional holders

Quarters

Q4 2025Q1 2024Q4 2023Q3 2023Q2 2023
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q4 2025

Motiv8 Investments LLC1
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Motiv8 Investments LLC
1$00.0%GrowthMediumPort St. Lucie, FL2026-02-13